KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TAK) Debt Ratio (2018 - 2025)

Historic Debt Ratio for Takeda Pharmaceutical (TAK) over the last 8 years, with Q4 2025 value amounting to 0.31.

  • Takeda Pharmaceutical's Debt Ratio fell 1042.06% to 0.31 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.31, marking a year-over-year decrease of 1042.06%. This contributed to the annual value of 0.32 for FY2025, which is 110.93% down from last year.
  • According to the latest figures from Q4 2025, Takeda Pharmaceutical's Debt Ratio is 0.31, which was down 1042.06% from 0.34 recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Debt Ratio ranged from a high of 0.39 in Q2 2021 and a low of 0.31 during Q1 2023
  • In the last 5 years, Takeda Pharmaceutical's Debt Ratio had a median value of 0.34 in 2025 and averaged 0.34.
  • In the last 5 years, Takeda Pharmaceutical's Debt Ratio plummeted by 1329.21% in 2021 and then skyrocketed by 689.04% in 2024.
  • Takeda Pharmaceutical's Debt Ratio (Quarter) stood at 0.37 in 2021, then fell by 11.48% to 0.33 in 2022, then increased by 3.92% to 0.34 in 2023, then increased by 3.1% to 0.35 in 2024, then dropped by 10.42% to 0.31 in 2025.
  • Its last three reported values are 0.31 in Q4 2025, 0.34 for Q3 2025, and 0.33 during Q2 2025.